Down-regulation of TNF-$\alpha$ and IL-6 by Higenamine is Responsible for Reduction of Infarct Size and Myocardial Ischemic Injury in the Rat

  • Lee, Young-Soo (Department of Pharmacology, Istitute of Hearth Science, College of Medicine, Gyeongsang National University) ;
  • Kang, Young-Jin (Department of Pharmacology, Istitute of Hearth Science, College of Medicine, Gyeongsang National University) ;
  • Lee, Bog-Kyu (Department of Pharmacology, Istitute of Hearth Science, College of Medicine, Gyeongsang National University) ;
  • Ko, Young-Shim (Department of Pharmacology, Istitute of Hearth Science, College of Medicine, Gyeongsang National University) ;
  • Park, Min-Kyu (Department of Pharmacology, Istitute of Hearth Science, College of Medicine, Gyeongsang National University) ;
  • Seo, Han-Geuk (Department of Pharmacology, Istitute of Hearth Science, College of Medicine, Gyeongsang National University) ;
  • Yun-Choi, Hye-Sook (Department of Pharmacology, Istitute of Hearth Science, College of Medicine, Gyeongsang National University) ;
  • Chang, Ki-Churl (Department of Pharmacology, Istitute of Hearth Science, College of Medicine, Gyeongsang National University)
  • Published : 2001.09.01

Abstract

Recent studies have shown that cytokines are capable of modulating cardiovascular function and that some drugs used in the treatment of heart failure variably modulate the production of cytokines. Hige- namine, a positive inotropic isoquinoline alkaloid, has been used traditionally as cardiac stimulant, and reported to reduce nitric oxide (NO) and inducible nitric oxide synthase (iNOS) expression in LPS- and/or cytokine-activated cells in vitro and in vivo. Therefore, we investigated whether higenamine modulates the production of proinflammatory cytokines in myocardial infarction. In addition, effects of higenamine on antioxidant action and antioxidant enzyme expression (MnSOD) were studied. Myocardial infarction (MI) was confirmed by measuring left ventricular (LV) pressure after occlusion of the left anterior descending coronary artery (LAD) for 5 weeks in rats. Treatment of higenamine (10 mg/kg/day) reduced infarct size about 35 %, which accompanied by reduction of production TNF-$\alpha$, IL-6, but not IFN-${\gamma}$ and IL-1$\beta$ in the myocardium. The expression of TNF-$\alpha$ mRNA in infracted myocardium was significantly reduced by higenamine. Although iNOS mRNA was not detected, nitrotyrosine staining was significantly increased in myocardium of Ml compared to higenamine-treated one, Indicating that peroxynitrite-induced damage is evident in MI. Cytochrome c oxidation by peroxynitrite was concentration-dependently reduced by higenamine, an effect which was almost compatible to glutathion. Higenamine treatment did not affect the expression of MnSOD mRNA in myocardial tissues in MI. Taken together, higenamine may be beneficial in oxidative stress conditions such as ischemic-reperfusion injury and MI due to antioxidant action as well as modulation of cytokines.

Keywords